Tyrosine hydroxylase inhibits HCC progression by downregulating TGFβ/Smad signaling

Guoqian Liu1,2, Mengwei Li1,2, Zimei Zeng2

  • 1Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, 410008, Hunan, China.

Insights

Tyrosine hydroxylase (TH) is reduced in liver cancer (HCC), but higher TH levels improve patient survival. This enzyme inhibits HCC growth and metastasis, suggesting TH as a diagnostic biomarker and therapeutic target.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Metabolic alterations are crucial in hepatocellular carcinoma (HCC) development.
  • The role of tyrosine metabolism dysfunction in HCC remains unclear.

Purpose of the Study:

  • To investigate the function of tyrosine hydroxylase (TH) in hepatocellular carcinoma (HCC).
  • To explore TH as a potential biomarker and therapeutic target for HCC.

Main Methods:

  • Quantification of TH expression in HCC tissues.
  • Analysis of the correlation between TH levels and clinical parameters.
  • Investigation of TH's effect on HCC cell growth and metastasis in vitro.
  • Exploration of TH's interaction with the TGFβ/Smad signaling pathway.

Main Results:

  • TH expression is reduced in HCC, and higher TH levels correlate with improved patient survival.
  • Decreased TH is associated with larger tumor size, increased tumor number, higher AFP levels, and cirrhosis.
  • TH inhibits HCC cell proliferation and metastasis by impairing serine phosphorylation (S19/S40).
  • TH directly binds Smad2, inhibiting TGFβ/Smad signaling activation.

Conclusions:

  • TH possesses non-metabolic functions critical to HCC development.
  • TH may serve as a valuable diagnostic biomarker for HCC.
  • TH represents a potential therapeutic target for metastatic HCC.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K